ALVO
HEALTHCAREAlvotech
$3.57+0.07 (+2.00%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving ALVO Today?
No stock-specific AI insight has been generated for ALVO yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$3.03$11.85
$3.57
Fundamentals
Market Cap$1.1B
P/E Ratio35.7
EPS$0.10
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin0.0%
Debt / Equity—
Trading
Volume473K
Avg Volume (10D)—
Shares Outstanding312.0M
ALVO News
22 articles- Alvotech’s Earnings Swing And Counsel Exit Might Change The Case For Investing In ALVOYahoo Finance·May 8, 2026
- Alvotech Q1 Earnings Call HighlightsMarketbeat·May 7, 2026
- Alvotech (ALVO) Reports Q1 Loss, Lags Revenue EstimatesYahoo Finance·May 7, 2026
- Alvotech Q1 2026 Financial ResultsYahoo Finance·May 6, 2026
- Alvotech Announces a Change in its Executive TeamYahoo Finance·Apr 30, 2026
- Alvotech (ALVO) Valuation Gap Under Review After Mixed Share Performance And Biosimilar Pipeline ProgressYahoo Finance·Apr 26, 2026
- Alvotech to Report Financial Results for the First Quarter of 2026Yahoo Finance·Apr 24, 2026
- Here’s What the Street Thinks About Alvotech (ALVO)Yahoo Finance·Apr 20, 2026
- Alvotech (ALVO) Revenue Surges 21% Year-Over-Year in 2025Yahoo Finance·Apr 2, 2026
- Alvotech files Annual Report with the SECGlobeNewswire Inc.·Mar 30, 2026
- Alvotech birtir ársreikning á eyðublaði 20-FGlobeNewswire Inc.·Mar 30, 2026
- Alvotech birtir ársskýrslu fyrir árið 2025GlobeNewswire Inc.·Mar 30, 2026
- Alvotech Publishes 2025 Annual ReportGlobeNewswire Inc.·Mar 30, 2026
- Statutory Earnings May Not Be The Best Way To Understand Alvotech's (NASDAQ:ALVO) True PositionYahoo Finance·Mar 26, 2026
- Did Alvotech’s (ALVO) Profitability Turn and Expanding Biosimilar Pipeline Just Recast Its Investment Narrative?Yahoo Finance·Mar 20, 2026
- Alvotech Q4 Earnings Call HighlightsMarketbeat·Mar 19, 2026
- Exchange-Traded Funds, Equity Futures Lower Pre-Bell Thursday Amid Rising Oil Prices, Reduced Rate-Cut ExpectationsYahoo Finance·Mar 19, 2026
- Alvotech Q4 2025 and Full Year 2025 Financial ResultsYahoo Finance·Mar 18, 2026
- Alvotech (ALVO) Q4 2025 Earnings Report Preview: What To Look ForYahoo Finance·Mar 18, 2026
- Alvotech (ALVO) Q4 2025 Earnings Report Preview: What To ExpectYahoo Finance·Mar 17, 2026
- Alvotech to Report Fourth Quarter and Full Year 2025 Financial ResultsYahoo Finance·Mar 4, 2026
- Is Alvotech (ALVO) Pricing Make Sense After A 64% One Year Share Price SlumpYahoo Finance·Feb 16, 2026
All 22 articles loaded
Price Data
Open$3.57
Previous Close$3.50
Day High$3.61
Day Low$3.47
52 Week High$11.85
52 Week Low$3.03
52-Week Range
$3.03$11.85
$3.57
Fundamentals
Market Cap$1.1B
P/E Ratio35.7
EPS$0.10
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin0.0%
Debt / Equity—
Trading
Volume473K
Avg Volume (10D)—
Shares Outstanding312.0M
About Alvotech
Alvotech Holdings SA, develops and manufactures biosimilars for global markets. The company is headquartered in Iceland.
HEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICDRUG MANUFACTURERS - SPECIALTY & GENERIC
CIK—
Composite FIGI—
Share Class FIGI—